Cancer patients get lifeline to continue promising treatment
NCT ID NCT05112965
Summary
This study allows cancer patients who were benefiting from atezolizumab treatment in previous Roche-sponsored trials to continue receiving their medication if it's not available through regular channels. The 49 participants can keep getting their treatment while researchers monitor safety. This provides continued access to a cancer-fighting drug for patients who were already responding well to it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Cancer Hospital
Beijing, 100142, China
-
Cancer Hospital of Shandong First Medical University
Jinan, Shandong, 250117, China
-
Changchun Cancer Hospital
Changchun, 130000, China
-
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, 150081, China
-
Henan Cancer Hospital
Zhengzhou, 450008, China
-
Hunan Cancer Hospital
Changsha, 410013, China
-
Jiangsu Cancer Hospital
Nanjing, 211100, China
-
Jilin Cancer Hospital
Changchun, 132013, China
-
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, 510515, China
-
Peking Union Medical College Hospital
Beijing, 100730, China
-
Shanghai Chest Hospital
Shanghai, 200000, China
-
Sir Run Run Shaw Hospital
Hangzhou, Zhejiang, 310016, China
-
The 2nd Hospital of Tianjin Medical University
Tianjin, 300211, China
-
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, 510120, China
-
Tianjin Cancer Hospital
Tianjin, 300060, China
-
Union Hospital of Tongji Medical College, Dept. of Cancer Center
Wuhan, Hubei, 430022, China
-
Zhejiang Cancer Hospital
Zhejiang, 310022, China
Conditions
Explore the condition pages connected to this study.